Neumedicines Inc.

Neumedicines Inc. is a clinical stage biopharmaceutical company based in Pasadena, California, focused on developing innovative immunotherapeutic treatments for cancer. Their lead product, HemaMax, aims to enhance immune responses and hematopoiesis to achieve durable cancer treatment outcomes.